HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,018,891 | +29.1% | 33,701 | +22.7% | 0.00% | 0.0% |
| Q2 2023 | $2,338,796 | +11.8% | 27,470 | -93.2% | 0.00% | 0.0% |
| Q1 2023 | $2,091,480 | -6.1% | 406,531 | +1335.9% | 0.00% | 0.0% |
| Q4 2022 | $2,226,739 | +10.5% | 28,312 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $2,016,000 | +27.8% | 27,234 | +12.6% | 0.00% | 0.0% |
| Q2 2022 | $1,577,000 | +0.9% | 24,189 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $1,563,000 | +92.7% | 24,716 | +61.6% | 0.00% | – |
| Q4 2021 | $811,000 | -29.0% | 15,299 | -5.5% | 0.00% | -100.0% |
| Q3 2021 | $1,143,000 | -10.6% | 16,189 | -15.6% | 0.00% | 0.0% |
| Q2 2021 | $1,278,000 | -62.3% | 19,175 | -37.3% | 0.00% | -50.0% |
| Q1 2021 | $3,394,000 | -4.2% | 30,572 | +2.5% | 0.00% | -33.3% |
| Q4 2020 | $3,542,000 | +67.2% | 29,824 | +22.8% | 0.00% | +50.0% |
| Q3 2020 | $2,118,000 | +46.6% | 24,279 | +50.4% | 0.00% | +100.0% |
| Q2 2020 | $1,445,000 | +7.7% | 16,139 | +19.9% | 0.00% | -50.0% |
| Q1 2020 | $1,342,000 | +15.6% | 13,464 | +33.2% | 0.00% | +100.0% |
| Q4 2019 | $1,161,000 | -4.0% | 10,105 | +5.3% | 0.00% | 0.0% |
| Q3 2019 | $1,210,000 | +98.4% | 9,594 | +89.1% | 0.00% | 0.0% |
| Q2 2019 | $610,000 | +81.0% | 5,073 | +31.7% | 0.00% | – |
| Q1 2019 | $337,000 | -76.4% | 3,852 | -73.0% | 0.00% | -100.0% |
| Q4 2018 | $1,430,000 | -11.6% | 14,293 | -20.8% | 0.00% | -50.0% |
| Q2 2018 | $1,618,000 | -14.8% | 18,049 | -30.5% | 0.00% | -20.0% |
| Q1 2018 | $1,899,000 | +22.6% | 25,955 | -2.7% | 0.01% | +66.7% |
| Q4 2017 | $1,549,000 | +29.8% | 26,665 | +0.3% | 0.00% | 0.0% |
| Q3 2017 | $1,193,000 | +3.8% | 26,572 | -8.8% | 0.00% | 0.0% |
| Q2 2017 | $1,149,000 | +11.8% | 29,140 | +14.9% | 0.00% | 0.0% |
| Q1 2017 | $1,028,000 | +1.7% | 25,371 | +0.9% | 0.00% | -25.0% |
| Q4 2016 | $1,011,000 | +10.3% | 25,146 | -0.7% | 0.00% | 0.0% |
| Q3 2016 | $917,000 | +24.8% | 25,329 | -0.0% | 0.00% | +33.3% |
| Q2 2016 | $735,000 | -25.2% | 25,337 | -9.8% | 0.00% | -25.0% |
| Q1 2016 | $982,000 | +19.8% | 28,087 | +10.5% | 0.00% | 0.0% |
| Q4 2015 | $820,000 | -4.3% | 25,429 | -4.1% | 0.00% | 0.0% |
| Q3 2015 | $857,000 | -30.7% | 26,526 | -11.3% | 0.00% | -33.3% |
| Q2 2015 | $1,237,000 | -22.5% | 29,899 | -15.8% | 0.01% | -25.0% |
| Q1 2015 | $1,596,000 | +7154.5% | 35,530 | +5891.6% | 0.01% | – |
| Q4 2014 | $22,000 | +4.8% | 593 | 0.0% | 0.00% | – |
| Q3 2014 | $21,000 | +10.5% | 593 | +11.9% | 0.00% | – |
| Q2 2014 | $19,000 | +90.0% | 530 | +71.5% | 0.00% | – |
| Q1 2014 | $10,000 | -63.0% | 309 | -52.5% | 0.00% | – |
| Q4 2013 | $27,000 | +80.0% | 650 | +68.0% | 0.00% | – |
| Q3 2013 | $15,000 | -25.0% | 387 | -19.9% | 0.00% | – |
| Q2 2013 | $20,000 | – | 483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |